Cited by 336Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseViral Infections and Immunology Research

The DOI matches its Crossref record; 318 of the 318 references it cites were found in a registry or an index.

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Writing Committee Members, Ommen, Steve R., Mital, Seema, Burke, Michael A., Day, Sharlene M., Deswal, Anita, Elliott, Perry, Evanovich, Lauren L., Hung, Judy, Joglar, José A., Kantor, Paul, Kimmelstiel, Carey, Kittleson, Michelle, Link, Mark S., Maron, Martin S., Martinez, Matthew W., Miyake, Christina Y., Schaff, Hartzell V., Semsarian, Christopher, Sorajja, Paul·2020·Circulation

DOI 10.1161/cir.0000000000000938

Open this paper in CoChat — free account

Abstract

Aim: This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. Methods: A comprehensive literature search was conducted from January 1, 2010, to April 30, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Structure: Many recommendations from the earlier hypertrophic cardiomyopathy guidelines have been updated with new evidence or a better understanding of earlier evidence. This summary operationalizes the recommendations from the full guideline and presents a combination of diagnostic work-up, genetic and family screening, risk stratification approaches, lifestyle modifications, surgical and catheter interventions, and medications that constitute components of guideline directed medical therapy. For both guideline-directed medical therapy and other recommended drug treatment regimens, the reader is advised to follow dosing, contraindications and drug-drug interactions based on product insert materials.

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000000938

Cites

318 of 318 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Self-citation
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,380
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000503 · Cited by 2,544
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,234
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Self-citation

Show all 317 references

Research works printed but not linked: 1

10.1161/jaha.116.005152 · DOI

Sorted by citations

Items 101–200 of 336

Safety and efficacy of alcohol septal ablation in adolescents and young adults with hypertrophic obstructive cardiomyopathy
Lawin, D., Lawrenz, T., Radke, K., & Stellbrink, C. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01960-6 · Cited by 10
Sudden cardiac death risk in hypertrophic cardiomyopathy: comparison between echocardiography and magnetic resonance imaging
Śpiewak, M., Kłopotowski, M. M., Kowalik, E., Kubik, A., Ojrzyńska, N., Petryka, J., Michalak, E., Mazurkiewicz, Ł., Gawor, M., Kożuch, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86532-4 · Cited by 10
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction
Barbieri, A., Imberti, J. F., Bartolomei, M., Bonini, N., Laus, V., Triglia, L. T., Chiusolo, S., Stuani, M., Mari, C., Muto, F., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175525 · Cited by 9
Evolution and Transformation of Hypertrophic Cardiomyopathy From a High Risk to a Treatable Low Mortality Disease With Contemporary Clinical Research Strategies
Maron, B. J., Ommen, S. R., Nishimura, R. A., McKenna, W. J., Rakowski, H., Sherrid, M. V., Olivotto, I., Braunwald, E., & Maron, M. S. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.047462 · Cited by 9
Self-citation
Protein quality control systems in hypertrophic cardiomyopathy: pathogenesis and treatment potential.
Luo, F., Bai, Y., & Bu, H. (2022) · PubMed Central · doi:10.11909/j.issn.1671-5411.2022.10.010 · Cited by 9
Radiomics from Cardiovascular MR Cine Images for Identifying Patients with Hypertrophic Cardiomyopathy at High Risk for Heart Failure
Zhang, H., Zhao, L., Wang, H., Yi, Y., Hui, K., Zhang, C., & Ma, X. (2024) · Radiology Cardiothoracic Imaging · doi:10.1148/ryct.230323 · Cited by 10
Septal myectomy with mitral valve surgery in patients after alcohol septal ablation
Rudenko, K. V., Lazoryshynets, V. V., Nevmerzhytska, L. O., Tregubova, M., & Danchenko, P. A. (2022) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivac010 · Cited by 9
Diabetes outcomes in heart failure patients with hypertrophic cardiomyopathy
Mekhaimar, M., Almohannadi, M., Dargham, S. R., Suwaidi, J. M. S. A., Jneid, H. M., & Khalil, C. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.976315 · Cited by 9
Different Phenotypes of Sarcomeric MyBPC3-Cardiomyopathy in the Same Family: Hypertrophic, Left Ventricular Noncompaction and Restrictive Phenotypes (in Association with Sarcoidosis)
Blagova, O. V., Pavlenko, E. V., Парисович, С. В., Коган, Е. А., Polyak, M. E., Zaklyazminskaya, E. V., & Lutokhina, Y. A. (2022) · Genes · doi:10.3390/genes13081344 · Cited by 8
A MYH7 variant in a five-generation-family with hypertrophic cardiomyopathy
Franke, M., Książczyk, T. M., Dux, M., Chmielewski, P., Truszkowska, G. T., Czapczak, D., Pietrzak, R., Bilińska, Z. T., Demkow, U. A., & Werner, B. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1306333 · Cited by 8
Ventricular Repolarization Dispersion is a Potential Risk for the Development of Life-Threatening Arrhythmia in Children with Hypertrophic Cardiomyopathy
Tashiro, N., Muneuchi, J., Ezaki, H., Kobayashi, M., Yamada, H., Sugitani, Y., & Watanabe, M. (2022) · Pediatric Cardiology · doi:10.1007/s00246-022-02867-3 · Cited by 8
An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve
Cao, Y., Zheng, Y., Li, S., Liu, F., Xue, Z., Yin, K., & Luo, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.899906 · Cited by 8
Cascade testing for inherited cardiac conditions: Risk perception and screening after a negative genetic test result
Fusco, K., Hylind, R. J., Cirino, A. L., Harris, S. L., Lubitz, S. A., Abrams, D. J., & Lakdawala, N. K. (2022) · Journal of Genetic Counseling · doi:10.1002/jgc4.1602 · Cited by 8
Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy
Ismail, H., Bradley, A. J., & Lewis, J. F. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.834738 · Cited by 8
Different clinical characteristics and outcomes of hypertrophic cardiomyopathy with and without hypertension: seeking the truth
ZHANG, Y., Ming-Hao, L. I. U., Zhang, M., Wu, G., Liu, J., Wang, J., Sun, X., JIANG, W., Wang, D., Kang, L., et al. (2023) · 老年心脏病学杂志：英文版 · doi:10.26599/1671-5411.2023.02.007 · Cited by 8
Ventajas competitivas y tamaño de las empresas las PYME
Guillén, M. J. Y., & Félez, A. J. M. L. (1989) · Papeles de economía española/Papeles de economía española · Cited by 8
South Asian-Specific MYBPC3Δ25bp Deletion Carriers Display Hypercontraction and Impaired Diastolic Function Under Exercise Stress
Bazrafshan, S., Sibilia, R. S., Girgla, S. S., Viswanathan, S. K., Puckelwartz, M. J., Sangha, K. S., Singh, R. R., Kakroo, M. A., Jandarov, R., Harris, D. M., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.766339 · Cited by 7
Mitral regurgitation mechanisms related to systolic anterior motion in hypertrophic cardiomyopathy
Hayashi, H., Singh, S. K., Hahn, R. T., Akita, K., Kurlansky, P. A., Sun, J., Vedula, V., Leb, J. S., Shimada, Y. J., Weiner, S. D., et al. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1206 · Cited by 7
Myocardial bridging in obstructive hypertrophic cardiomyopathy: a risk factor for myocardial fibrosis
Song, C., Wang, S., Guo, X., Huang, M., Zheng, X., Lu, J., Ji, K., Zhao, S., Cui, J., Wang, S., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03301-6 · Cited by 7
Incremental prognostic value of left atrial strain in apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
Tang, Y., Ma, X., Wang, J., Yang, S., Dong, Z., Chen, X., Zhao, K., Wei, Z., Xu, J., Song, Y., et al. (2024) · European Radiology · doi:10.1007/s00330-024-11058-y · Cited by 7
Pathogenic genes and clinical prognosis in hypertrophic cardiomyopathy
Hong, Y., Xi, H.-T., Yang, X.-Y., SU, W. W., & Li, X. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i1.99595 · Cited by 7
Case Report: Practice of whole-course pharmaceutical care: a case in hypertrophic cardiomyopathy and a review of the pharmacist’s role
Li, L., Zhang, S., Sun, J.-B., Xu, Y., & Mao, K. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1512784 · Cited by 7
Size Matters. Prevalence and Clinical Implications of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy: A Systematic Review and Meta‐Analysis
Linden, K., Green, N., Muir, A., Malcolmson, J. W., MOHIDDIN, S. A., & O’Mahony, C. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.037234 · Cited by 7
Non-pharmaceutical Interventions for Hypertrophic Cardiomyopathy: A Mini Review
He, M., Qiu, J., Bai, Y., Wang, Y., Hu, M. Y., & Chen, G. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.695247 · Cited by 7
The Effect of Angiotensin II Receptor Blockers in Patients with Hypertrophic Cardiomyopathy: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials
Abdelazeem, B., Abbas, K. S., Ahmad, S., Raslan, H., Labieb, F., & Savarapu, P. K. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2304141 · Cited by 7
Magnetic Resonance Left Ventricle Mass-Index/Fibrosis: Long-Term Predictors for Ventricular Arrhythmia in Hypertrophic Cardiomyopathy—A Retrospective Registry
Khan, H. R., Rodwell, P., Taha, A. H., Goha, A. M., Ahmed, M., Thain, A., Somarakis, K., Al‐Atta, A., Erhayiem, B., Uddin, A., et al. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10030120 · Cited by 7
Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Systematic Review and Meta-analysis of Anticoagulation Strategy
Oliveri, F., Pepe, A., Bongiorno, A., Fasolino, A., Gentile, F. R., Schirinzi, S., Colombo, D., Breviario, F., Greco, A., Turco, A., et al. (2023) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00580-x · Cited by 7
The Role of Cardiovascular Magnetic Resonance Imaging in Patients with Cardiac Arrhythmias
Nikolaidou, C., Ormerod, J. O. M., Ziakas, A., Neubauer, S., & Karamitsos, T. D. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2409252 · Cited by 7
Comparison of left ventricular mass and wall thickness between cardiac computed tomography angiography and cardiac magnetic resonance imaging using machine learning algorithms
van Driest, F. Y., van der Geest, R. J., Omara, S., Broersen, A., Dijkstra, J., Jukema, J. W., & Scholte, A. J. H. A. (2024) · European Heart Journal - Imaging Methods and Practice · doi:10.1093/ehjimp/qyae069 · Cited by 7
Automated Quantification of Abnormal QRS Peaks From High‐Resolution ECGs Predicts Late Ventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 5‐Year Prospective Multicenter Study
Suszko, A. M., Chakraborty, P., Viswanathan, K., Barichello, S., Sapp, J. L., Talajic, M. R., Laksman, Z., Yee, R., Woo, A., SPEARS, D. A., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026025 · Cited by 7
The role of imaging in the selection of patients for HFpEF therapy
Baron, T., Gerovasileiou, S., & Flachskampf, F. A. (2023) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jead137 · Cited by 7
Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction
Maeder, M. T., Weber, L., Buser, M., Brenner, R., Joerg, L., & Rickli, H. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.694240 · Cited by 7
Hypertrophic Cardiomyopathy
Butt, A. K., Alkhatib, D. A., Pour‐Ghaz, I., Isa, S. O., Al-Taweel, O., Ugonabo, I., Yedlapati, N., & Jefferies, J. L. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10030106 · Cited by 7
Discontinuation of afterload-reducing drugs decreases left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy
Derda, A. A., Abelmann, M., Sonnenschein, K., Sieweke, J.-T., Bavendiek, U., Bauersachs, J., Thum, T., & Berliner, D. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1403422 · Cited by 6
Endoplasmic reticulum stress in cardiomyopathies: from the unfolded protein response to therapeutic opportunities
Qiu, Y., Chen, Z., He, P., & Wang, Z. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1577186 · Cited by 7
Radiofrequency ablation in patients with obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis
Canzi, C. C., Júnior, E. R. D. P., Menezes, A. D. S., Rezende, A. L., Botelho, S. M., & Santos, L. D. R. (2022) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2022.100229 · Cited by 6
The Risk of Ventricular Arrhythmias between Alcohol Septal Ablation and Septal Myectomy in Hypertrophic Cardiomyopathy: A Meta-Analysis on Septal Reduction Therapy
Tang, W., Liu, M., Li, J., Chang, R., Chen, S., Zhang, X., & Wang, L. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2312391 · Cited by 6
Current perspectives of sudden cardiac death management in hypertrophic cardiomyopathy
Pu, L., Li, J., Qi, W., Zhang, J., Chen, H., Tang, Z., Han, Y., Wang, J., & Chen, Y. (2023) · Heart Failure Reviews · doi:10.1007/s10741-023-10355-w · Cited by 6
Fractal analysis in cardiovascular magnetic resonance: prognostic value of biventricular trabecular complexity in hypertrophic cardiomyopathy
Jiang, W., Chen, B., Zhang, C., Shi, R., Wu, R., An, D., Ma, X., Wesemann, L. D., Hu, J., Zhou, Y., et al. (2023) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-23-162 · Cited by 6
The burden and management competency of cardiomyopathies in China: a nationwide survey study
Zhang, Y., Liu, M., Li, P., Ma, L., Yin, L., Cui, Y., Huang, K., Li, W., Xin, H., Xiang, M., et al. (2024) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2024.101062 · Cited by 7
A personalized mRNA signature for predicting hypertrophic cardiomyopathy applying machine learning methods
Gu, J., Zhao, Y., Ben, Y., Zhang, S., Hua, L., He, S., Liu, R., Xu, C. Y., & Sheng, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-67201-8 · Cited by 6
Influencing and Prognostic Factors of End-Stage Hypertrophic Cardiomyopathy
Zhang, Y., Xie, W., Dai, Y., Wu, Z., Lin, Y., Yang, M., & Hong, H. (2024) · ESC Heart Failure · doi:10.1002/ehf2.15010 · Cited by 6
Clinical and Genetic Heterogeneity of HCM: The Possible Role of a Deletion Involving MYH6 and MYH7
Mancuso, G., Marsan, M., Neroni, P., Soddu, C., Lai, F., Serventi, L., Cau, M., Coiana, A., Incani, F., Murru, S., et al. (2025) · Genes · doi:10.3390/genes16020212 · Cited by 6
Holter Monitor Rhythm Parameters in Healthy Infants, Children, and Adolescents: Defining Reference Limits With Meta‐Analysis
Joyce, J. J., Bogarapu, S., Odhiambo, C. O., Ferns, S. J., & Kennedy, H. L. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.039783 · Cited by 6
Establishment of a Dedicated Inherited Cardiomyopathy Clinic: From Challenges to Improved Patients’ Outcome
Smith, E., Thompson, P. D., Burke‐Martindale, C., & Weissler‐Snir, A. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024501 · Cited by 6
Prospects for remodeling the hypertrophic heart with myosin modulators
Sewanan, L. R., & Shimada, Y. J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1051564 · Cited by 6
Solving the Riddle of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: The Added Role of Cardiac Magnetic Resonance
Stankowski, K., Figliozzi, S., Lisi, C., Catapano, F., Panico, C., Cannata, F., Mantovani, R., Frontera, A., Bragato, R., Stefanini, G. G., et al. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10060226 · Cited by 6
Role of cardiac imaging in management of heart failure
Kim, S. R., & Park, S. (2023) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2023.262 · Cited by 6
Evaluation of global and regional myocardial work in hypertrophic cardiomyopathy patients by left ventricular pressure-strain loop
Xiao, C., Zhao, X., Sun, L., & Zhang, F. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03519-x · Cited by 6
An overview of the treatments for hypertrophic cardiomyopathy
Xu, W., Zhu, F., Zhang, Y., Li, P., & Sheng, Y. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1387596 · Cited by 6
Assessing Cardiovascular Health in Paediatric Hypertrophic Cardiomyopathy Using the CANHEART Health Index
Srbely, V., Jeewa, A., Pidborochynski, T., Lemaire‐Paquette, S., Khoury, M., Cunningham, C., Dhillon, S., Laroussi, N. A., Vaujois, L., Dallaire, F., et al. (2024) · CJC Pediatric and Congenital Heart Disease · doi:10.1016/j.cjcpc.2024.06.002 · Cited by 6
Recent Clinical Updates of Hypertrophic Cardiomyopathy and Future Therapeutic Strategies
Zhao, M., He, X., Min, X., Yang, H., Wu, W., Zhong, J., Xu, H., & Chen, J. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm25132 · Cited by 6
Comparing the efficacy and safety of medications in adults with hypertrophic cardiomyopathy: a systematic review and network meta-analysis
Mi, K., Wu, S., Lv, C., Meng, Y., Yin, W., Li, H., Li, J., & Yuan, H. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1190181 · Cited by 6
RAF1 mutation leading to hypertrophic cardiomyopathy in a Chinese family with a history of sudden cardiac death: A diagnostic insight into Noonan syndrome
Zheng, J., Peng, L., Cheng, R., Li, Z., Xie, J., Huang, E., Cheng, J., & Zhao, Q. (2023) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2290 · Cited by 6
Feasibility study of cryoballoon ablation for atrial fibrillation with KODEX-EPD: a single center experience
Wubulikasimu, S., Wang, L., Yang, S., Sang, W., Han, Y., Wang, L., Wang, F., Zhou, X., Zhang, J., Xing, Q., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-49475-6 · Cited by 6
Preintervention imaging and intraoperative management care of the hypertrophic obstructive cardiomyopathy patient
Garijo, J. M., Ibáñez, C., Perdomo, J. M., Abel, M., & Meineri, M. (2021) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/02184923211047126 · Cited by 6
Significant Variation in Exercise Recommendations for Youth With Cardiomyopathies or Fontan Circulation
Khoury, M., Wittekind, S. G., Lal, A. K., Conway, J. L., Bansal, N., Lorts, A., Rosenthal, D. N., & Burstein, D. S. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.008738 · Cited by 6
Improvement in coronary microvascular dysfunction evaluated by cardiac magnetic resonance in patients with hypertrophic obstructive cardiomyopathy after transapical beating-heart septal myectomy
Zhao, Y. L., Huang, L., Li, C., Tang, D., Luo, Y., Xiang, C., Zhou, X., Fang, J., Wei, X., & Xia, L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1233004 · Cited by 5
Apical Sparing of Longitudinal Strain as a Specific Pattern of Myocardial Fibrosis in Patients with Severe Left Ventricular Hypertrophy: A Comparison between Deformation Imaging and Histological Findings
Yelenski, S., Zayat, R., Spillner, J. W., Donuru, S., Kolashov, A., Khattab, M. A., Hatam, N., & Kalverkamp, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206141 · Cited by 5
Exploring the Current Status of Risk Stratification in Hypertrophic Cardiomyopathy: From Risk Models to Promising Techniques
Kasiakogias, A., Kaskoutis, C., Antoniou, C. K., Georgopoulos, S., Tsiachris, D., Αρσένος, Π., Kouroutzoglou, A., Klettas, D., Vlachopoulos, C. V., Tsioufis, K. P., et al. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12030101 · Cited by 5
Rewiring the scar: translational advances in cardiac fibrosis
Trần, T. N. H., Le, P. H., Yang, S., Luong, T., & Kim, J. (2025) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.25.160 · Cited by 5
Assessment of cardiac dimensions in children diagnosed with hypertrophic cardiomyopathy
Bakaya, K., Paracha, W., Schievano, S., & Bozkurt, S. (2022) · Echocardiography · doi:10.1111/echo.15437 · Cited by 5
Tissue-level evidence of fibroblast activation protein inhibitor imaging in hypertrophic obstructive cardiomyopathy: a case series
Li, L., Gao, J., Liu, X., Chen, B.-X., Su, P., & Xie, B. (2024) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytae189 · Cited by 5
Yield of family screening for dilated cardiomyopathy: 10-year experience at a multidisciplinary cardiogenetic outpatient clinic
Thierry, I. P., Muller, S. A., Baas, A. F., Dooijes, D., van Loon, R. L. E., Schoemaker, A. E., van der Harst, P., Oerlemans, M. I. F. J., Baars, H. F., Hassink, R. J., et al. (2025) · Netherlands Heart Journal · doi:10.1007/s12471-024-01924-1 · Cited by 5
Perinatal clinical course of Vici syndrome associated with novel EPG5 variants: unique cardiac changes and difficulty with foetal diagnosis
Shima, T., Kinjo, T., Park, S., & Sonoda, M. (2024) · BMJ Case Reports · doi:10.1136/bcr-2023-255847 · Cited by 5
Ultrastructural characteristics of myocardial mitochondria in hypertrophic cardiomyopathy with diffuse-generalized phenotype
Kozlova, M. A., Areshidze, D. A., Chernikov, V. P., Павловна, М. А., Evseev, E. P., Zaklyazminskaya, E. V., & Sl, D. (2024) · Clinical and Experimental Surgery Petrovsky journal · doi:10.33029/2308-1198-2024-12-1-7-14 · Cited by 5
Imaging for risk stratification of sudden cardiac death
van der Bijl, P., & Bax, J. J. (2022) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-022-00884-6 · Cited by 5
The MYH7 c.2770G > A (p.Glu924Lys) mutation exhibits phenotypic heterogeneity in hypertrophic cardiomyopathy (HCM) and restrictive cardiomyopathy (RCM): a case report
Han, Y., Wang, H., Zhang, H., Wang, M., Gan, L., & Meng, F. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04943-x · Cited by 4
Primary cardiomyopathies in childhood: clinical and diagnostic features (literature review)
Plotnikova, I. V., Свинцова, Л. И., Dzhaffarova, O. Y., Олеговна, К. Е., Perevoznikova, Y. E., & Pavlyukova, E. N. (2022) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2022-37-3-65-74 · Cited by 4
The triglyceride-glucose index as a potential protective factor for hypertrophic obstructive cardiomyopathy without diabetes: evidence from a two-center study
Meng, X., Gao, J. L., Zhang, K., Jun, W., Wang, J., Wang, X., Wang, Y.-G.-S., Zheng, J., Liu, Y.-P., Song, J., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01084-z · Cited by 4
Effects of sex on clinical outcomes of hypertrophic cardiomyopathy in Singapore
Li, T. Y., Yeo, S., Ngiam, J. N., Lee, C., Low, T. T., Lim, Y. C., Evangelista, L. K. M., Lee, E. C. Y., Sari, N. Y., Yeo, T., et al. (2023) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.2022344 · Cited by 4
Specifics of Left Ventricular Hypertrophy and Characteristic of Phenotypic Variants in Patients with Hypertrophic Cardiomyopathy
Игнатенко, Г. А., Тарадин, Г. Г., & Евгеньевна, К. Т. (2023) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2023-13-4-282-293 · Cited by 4
Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy
Verheyen, N., Auer, J., Bonaros, N. E., Buchacher, T., Dalos, D., Grimm, M. F., Mayr, A., Rab, A., Reinstadler, S. J., Scherr, D., et al. (2024) · Wiener klinische Wochenschrift · doi:10.1007/s00508-024-02442-1 · Cited by 4
Sociodemographic Disparities in Obtaining Cardiac MRI: Black, White, and Shades of Gray
Akingbade, O., Cabrera, E., Subashchandran, V., Yang, R., Shah, N., Patel, H. N., & Slivnick, J. A. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02219-6 · Cited by 4
Astragalus Polysaccharide Improves Myocardial Fibrosis in Hypertrophic Cardiomyopathy Through the TGF-β1/Smad3 Signal Pathway
Qin, N., Wu, W., & Li, B. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl45595 · Cited by 4
Association of QTc Interval and V4-S Wave With Appropriate ICD Therapy in Hypertrophic Cardiomyopathy
Zhang, N., Cheng, S., Niu, H., Gu, M., Peng, H., Sun, Z., Liu, X., Deng, Y., Chen, X., & Hua, W. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.882662 · Cited by 4
Association of Types of Sleep Apnea and Nocturnal Hypoxemia with Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
Xu, H., Wang, J., Qiao, S., Yuan, J., Hu, F., Yang, W., Guo, C., Luo, X., Duan, X. R., Liu, S., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041347 · Cited by 4
The Value of the Cardiac Magnetic Resonance Intravoxel Incoherent Motion Technique in Evaluating Microcirculatory Dysfunction in Hypertrophic Cardiomyopathy
Abulaiti, A., Zhang, Q., Huang, H., Ding, S., Shayiti, M., Wang, S., Wang, Y., & Jia, W. (2023) · Journal of Interventional Cardiology · doi:10.1155/2023/4611602 · Cited by 4
Identifying Obstructive Hypertrophic Cardiomyopathy from Nonobstructive Hypertrophic Cardiomyopathy: Development and Validation of a Model Based on Electrocardiogram Features
Guo, L., Ma, Z., Yang, W., Zhang, F., Shao, H., Liu, L., Gao, C., & Tao, L. (2023) · Global Heart · doi:10.5334/gh.1250 · Cited by 4
Invasive Cardiac Hemodynamics in Apical Hypertrophic Cardiomyopathy
Malik, A. A., Saraswati, U., Miranda, W. R., Covington, M. K., Scott, C. G., Lee, A. T., Arruda-Olson, A. M., Geske, J. B., Klarich, K. W., & Anand, V. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032520 · Cited by 4
Impaired longitudinal systolic–diastolic coupling and cardiac response to exercise in patients with hypertrophic cardiomyopathy
MacNamara, J. P., Turlington, W. M., Dias, K. A., Hearon, C. M., Ivey, E., Delgado, V. A., Brazile, T. L., Wakeham, D. J., Turer, A. T., Link, M. S., et al. (2024) · Echocardiography · doi:10.1111/echo.15857 · Cited by 4
Self-citation
Hypertrophic obstructive cardiomyopathy with a basal septal thickness of 16 mm or less: clinical characteristics and surgical results
Ji, Q., Wang, Y., Yang, Y., Lai, H., Xia, L., & Wang, C. (2022) · Surgery Today · doi:10.1007/s00595-021-02441-z · Cited by 4
Social Inequalities in Non-ischemic Cardiomyopathies
Amiya, E. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831918 · Cited by 4
Prognosis of patients with familial hypertrophic cardiomyopathy: A single-center cohort study with ten-year follow-up by propensity score matching analysis
He, Y., Yu, C., Zhou, L., Zhang, H., Ma, H., Liu, M., Tao, J., Hua, W., Liu, T., & Li, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17629 · Cited by 4
Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy
Li, L., Ban, C., Ruan, H., Zhang, M., Wang, Z., Ma, M., Zheng, Y., & He, S. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03562-8 · Cited by 4
Patterns of left ventricular trabeculation in hypertrophic cardiomyopathy
Zhang, Y., Zhou, D., Zhu, Y., Huang, Q., Wang, J., Zhang, C., Kang, L., Lu, M., & Song, L. (2025) · BMC Medicine · doi:10.1186/s12916-025-04142-7 · Cited by 3
Genotype-phenotype associations in sarcomeric hypertrophic cardiomyopathy associated with mutations in the MYBPC3 gene: Systematic review and meta-analysis
Nogueira-Garcia, B., Pinheiro, D., Gregório, C., Caldeira, D., Pinto, F. J., & Brito, D. A. (2025) · Journal of Cardiology · doi:10.1016/j.jjcc.2025.12.007 · Cited by 3
Cross-dataset transcriptomic analyses identify a conserved ENPP2+ macrophage–fibroblast activation axis in hypertrophic cardiomyopathy
Huang, F., Zhou, M., Chen, Y., Hua, S., Han, Y., Fan, Y., Li, Q., Sun, Z., Yang, K., Zhao, Q., et al. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag036 · Cited by 3
Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus
Bădescu, M. C., Șorodoc, V., Lionte, C., Ouatu, A., Haliga, R. E., Costache, A. D., Buliga-Finiș, O. N., Şimon, I., Șorodoc, L., Costache, I. I., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13010158 · Cited by 3
Case Report: Integrated echocardiographic assessment guided Liwen procedure for treating obstructive hypertrophic cardiomyopathy with ventricular aneurysm
Zhang, R., Zhao, F., Wang, J., Qin, Y., Wang, T., & Chu, A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1278457 · Cited by 3
Assessment of the structural and functional state of blood vessels in patients with hypertrophic cardiomyopathy
Bogatyreva, F. M., Kaplunova, V. Y., Kozhevnikova, M. V., Андрониковна, Ш. Г., Khabarova, N. V., Privalova, E. V., & Belenkov, Y. N. (2021) · Kardiologiia · doi:10.18087/cardio.2021.12.n1718 · Cited by 3
Case Report: A Chinese Family of Hypertrophic Cardiomyopathy Caused by a Novel Splicing Mutation in the FLNC Gene
Huang, C., Zheng, Y., Zhang, W., Chen, Z., Huang, Z. L., & Fang, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.894791 · Cited by 3
Effect of Perioperative Comprehensive Nursing Intervention on the Rehabilitation Effect of Radiofrequency Ablation for Patients with Hypertrophic Obstructive Cardiomyopathy
Xiang, X., Chen, Y., & Dai, L. (2022) · Contrast Media & Molecular Imaging · doi:10.1155/2022/6436073 · Cited by 3
Genomic findings of hypertrophic and dilated cardiomyopathy characterized in a Thai clinical genetics service
Trachoo, O., Yingchoncharoen, T., Ngernsritrakul, T., Iemwimangsa, N., Panthan, B., Klumsathian, S., Srisukh, S., Mukdadilok, A., Phusanti, S., Charoenyingwattana, A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267770 · Cited by 3
Sex-Related Differences among Adults with Hypertrophic Obstructive Cardiomyopathy Undergoing Transcoronary Ablation of Septal Hypertrophy
Alyaydin, E., Vogel, J. K., Luedike, P., Rassaf, T., Jánosi, R. A., & Παπαθανασίου, Μ. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12083024 · Cited by 3
Neonatal hypertrophic cardiomyopathy with dyspnoea as the first symptom: a case report
Li, X., Hong, S.-J., Hong, H., Zhang, Z., & Li, J. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1295539 · Cited by 3
European guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death 2022: cardiomyopathy. What’s new?
Novikova, Т. N., Bitakova, F. I., Ignateva, V., Novikov, V. I., Sayganov, S. A., & Shcherbakova, V. A. (2023) · Cardiac Arrhythmias · doi:10.17816/cardar567837 · Cited by 3
Promising therapies for adults with symptomatic obstructive hypertrophic cardiomyopathy: 2023 and beyond
Gaballa, A., Jadam, S., & Desai, M. Y. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2362902 · Cited by 3
A Machine Learning Approach to Gene Expression in Hypertrophic Cardiomyopathy
Pavić, J., Živanović, M., Tanasković, I., Pavić, O., Stanković, V., Virijević, K. D., Mladenović, T., Košarić, J. V., Miličević, B., Qamar, S. U. R., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17101364 · Cited by 3
Hypertrophic cardiomyopathy in the structure of infiltrative diseases in children
Gandaeva, L. A., & Basargina, E. N. (2023) · Russian Pediatric Journal · doi:10.46563/1560-9561-2023-26-3-152-158 · Cited by 2

Authors: Writing Committee Members, Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., Kimmelstiel, C., Kittleson, M., Link, M. S., Maron, M. S., Martinez, M. W., Miyake, C. Y., Schaff, H. V., Semsarian, C., & Sorajja, P.
Affiliations: ACC/AHA Representative.
American Hospital Association (US)
ASE Representative.
HRS Representative.
SCMR Representative.
AATS Representative.
SCAI Representative.
ORCID: Ommen, Steve R.
Mital, Seema
Burke, Michael A.
Day, Sharlene M.
Deswal, Anita
Hung, Judy
Joglar, José A.
Kantor, Paul
Kimmelstiel, Carey
Kittleson, Michelle
Link, Mark S.
Maron, Martin S.
Martinez, Matthew W.
Miyake, Christina Y.
Schaff, Hartzell V.
Semsarian, Christopher
Sorajja, Paul
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2020-12-22
Volume: 142
Issue: 25
Pages: e533-e557
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/cir.0000000000000938
OpenAlex: W3113392623
Cited by: 336
References: 317
Citations by year: 2026: 38 · 2025: 46 · 2024: 64 · 2023: 77 · 2022: 70 · 2021: 39 · 2020: 1
FWCI: 30.28
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords: hypertrophic cardiomyopathy, diagnosis, treatment, guideline-directed medical therapy, risk stratification, genetic screening, family screening, lifestyle modification, surgical treatment, interventional catheterization, medication, pediatric patients, adult patients
MeSH terms: Algorithms, American Heart Association, Cardiology, Cardiomyopathy, Hypertrophic, Decision Support Techniques, Humans, Predictive Value of Tests, United States, Treatment Outcome, Evidence-Based Medicine, Consensus, Cardiac Imaging Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks